These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24047137)

  • 1. Generation, validation, and application of a P450 homology model.
    Lewis BC; Miners JO
    Curr Top Med Chem; 2013; 13(18):2233-40. PubMed ID: 24047137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of homology modeling to generate CYP1A1 mutants with enhanced activation of the cancer chemotherapeutic prodrug dacarbazine.
    Lewis BC; Mackenzie PI; Miners JO
    Mol Pharmacol; 2011 Nov; 80(5):879-88. PubMed ID: 21816953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired dacarbazine activation and 7-ethoxyresorufin deethylation in vitro by polymorphic variants of CYP1A1 and CYP1A2: implications for cancer therapy.
    Lewis BC; Korprasertthaworn P; Miners JO
    Pharmacogenet Genomics; 2016 Oct; 26(10):453-61. PubMed ID: 27428168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation of dacarbazine by human cytochromes P450: the role of CYP1A1, CYP1A2, and CYP2E1.
    Reid JM; Kuffel MJ; Miller JK; Rios R; Ames MM
    Clin Cancer Res; 1999 Aug; 5(8):2192-7. PubMed ID: 10473105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.
    Lewis BC; Mackenzie PI; Miners JO
    Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation.
    Long L; Dolan ME
    Clin Cancer Res; 2001 Dec; 7(12):4239-44. PubMed ID: 11751525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 (CYP) mutants and substrate-specificity alterations: segment-directed mutagenesis applied to human CYP1A1.
    Urban P; Jobert AS; Lainé R; Pompon D
    Biochem Soc Trans; 2001 May; 29(Pt 2):128-35. PubMed ID: 11356140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate cytochrome P450 genes for ethoxyresorufin O-deethylase activity in oyster Crassostrea gigas.
    Siebert MN; Mattos JJ; Toledo-Silva G; Razzera G; Bainy ACD
    Aquat Toxicol; 2017 Aug; 189():142-149. PubMed ID: 28623690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring CYP1A1 as anticancer target: homology modeling and in silico inhibitor design.
    Sangamwar AT; Labhsetwar LB; Kuberkar SV
    J Mol Model; 2008 Nov; 14(11):1101-9. PubMed ID: 18665399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoactivation and activation of the cytochrome P450s.
    Ekins S; Ring BJ; Binkley SN; Hall SD; Wrighton SA
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):642-51. PubMed ID: 9877001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations.
    Kesharwani SS; Nandekar PP; Pragyan P; Rathod V; Sangamwar AT
    J Mol Recognit; 2016 Aug; 29(8):370-90. PubMed ID: 26916064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of substrate binding to cytochrome P450 1A1 using molecular modeling and kinetic analyses: case of residue 382.
    Liu J; Ericksen SS; Besspiata D; Fisher CW; Szklarz GD
    Drug Metab Dispos; 2003 Apr; 31(4):412-20. PubMed ID: 12642467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings.
    Nandekar PP; Sangamwar AT
    Expert Opin Drug Discov; 2012 Sep; 7(9):771-89. PubMed ID: 22716293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer.
    Chen L; Waxman DJ
    Curr Pharm Des; 2002; 8(15):1405-16. PubMed ID: 12052216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.
    Yakkundi A; McErlane V; Murray M; McCarthy HO; Ward C; Hughes CM; Patterson LH; Hirst DG; McKeown SR; Robson T
    Cancer Gene Ther; 2006 Jun; 13(6):598-605. PubMed ID: 16410820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen.
    Stiborová M; Sopko B; Hodek P; Frei E; Schmeiser HH; Hudecek J
    Cancer Lett; 2005 Nov; 229(2):193-204. PubMed ID: 16125300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(3-Alkyl-2-oxoimidazolidin-1-yl)-N-phenylbenzenesulfonamides as new antimitotic prodrugs activated by cytochrome P450 1A1 in breast cancer cells.
    Chavez Alvarez AC; Zarifi Khosroshahi M; Côté MF; Gagné-Boulet M; Fortin S
    Bioorg Med Chem; 2018 Oct; 26(18):5045-5052. PubMed ID: 30201525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.